Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2013 | 09-2013 | 06-2013 | 05-2013 | 03-2013 | |
| Operating Expenses | 1,448 | 1,215 | 1,300 | 0 | 1,471 |
| Operating Income | -1,448 | -1,215 | -1,300 | 0 | -1,471 |
| Interest Expense | 361 | 323 | 316 | 0 | 309 |
| Other Income | 1,940 | 79 | 1,805 | 0 | -1,990 |
| Pre-tax Income | 131 | -1,460 | 188 | 0 | -3,770 |
| Income Tax | N/A | N/A | 3 | 0 | N/A |
| Net Income Continuous | 131 | -1,460 | 186 | 0 | -3,770 |
| Net Income | $131 | $-1,460 | $186 | $0 | $-3,770 |
| EPS Basic Total Ops | 3.60 | -40.54 | 0.30 | N/A | -5.71 |
| EPS Basic Continuous Ops | 3.54 | -40.53 | 0.27 | N/A | -5.92 |
| EPS Diluted Total Ops | -13.21 | -41.14 | -0.60 | N/A | -5.71 |
| EPS Diluted Continuous Ops | 3.54 | -38.86 | 0.26 | N/A | -5.92 |
| EBITDA(a) | $-1,280 | $-1,094 | $-1,194 | $0 | $-1,556 |